- Home
- RCMT vs ALEC Comparison
RCMT vs ALEC Comparison
Compare RCMT & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RCMT | ALEC |
|---|---|---|
| Founded | 1971 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 298.8M | 275.8M |
| IPO Year | 1997 | 2019 |
Fundamental Metrics
Financial Performance| Metric | RCMT | ALEC |
|---|---|---|
| Price | $32.23 | $2.29 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 7 |
| Target Price | ★ $45.00 | $3.90 |
| AVG Volume (30 Days) | 58.1K | ★ 2.3M |
| Earning Date | 11-17-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 27.38 | N/A |
| EPS | ★ 1.20 | 0.70 |
| Revenue | ★ $186,737,000.00 | $21,045,000.00 |
| Revenue This Year | $10.26 | $214.33 |
| Revenue Next Year | $10.07 | N/A |
| P/E Ratio | $29.08 | ★ N/A |
| Revenue Growth | ★ 5.83 | N/A |
| 52 Week Low | $17.26 | $1.09 |
| 52 Week High | $43.68 | $2.76 |
Technical Indicators
Market Signals| Indicator | RCMT | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 24.78 | 58.67 |
| Support Level | $27.02 | $1.87 |
| Resistance Level | $32.39 | $2.32 |
| Average True Range (ATR) | 1.58 | 0.18 |
| MACD | -0.48 | 0.03 |
| Stochastic Oscillator | 11.40 | 94.17 |
Price Performance
Historical ComparisonAbout RCMT RCM Technologies Inc.
RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions, including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, and Europe.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.